Table 2 Clinical parameters of the “long-term” (more than 3 years) kidney transplant patients

Age (mean ± SD)

58.63

±

12.41

56.36

±

13.86

0.8009 ^M

ns

Sex (n (male), %)

5

63%

17

61%

> 0.9999 ^M

ns

DM (n, %)

3

38%

11

39%

> 0.9999 ^M

ns

CVD (n, %)

3

38%

10

36%

> 0.9999 ^M

ns

HTA (n, %)

8

100%

28

100%

> 0.9999 ^M

ns

BMI (mean ± SD)

28.7

±

4.477

24.95

±

6.794

0.0575 ^M

ns

ACEi/ARBs

2

25%

18

64%

0.1034 ^M

ns

Immunosuppression

PDN + CsA (n, %)

0

0%

1

4%

> 0.9999 ^M

ns

PDN + CsA + MPS (n, %)

0

0%

1

4%

> 0.9999 ^M

ns

PDN + TAC (n, %)

1

13%

0

0%

0.2222 ^M

ns

PDN + TAC + MPS (n, %)

6

75%

24

86%

0.5963 ^M

ns

PDN + TAC + EVE (n, %)

1

13%

2

7%

> 0.9999 ^M

ns

S.Creat (mean ± SD)

2.368

±

0.6803

2.277

±

0.7484

0.7865 ^M

ns

eGFR (mean ± SD)

27.75

±

9.067

32.79

±

17.18

0.5941 ^M

ns

Proteinuria (mean ± SD)

534.6

±

683.6

1562

±

1901

0.0363 ^M

*

Albuminuria (mean ± SD)

190.5

±

339.6

929.3

±

1262

0.0132 ^M

*

VTN (mean ± SD)

14.71

±

17.81

56.79

±

42.80

0.0040 ^M

**

VTN/U.Creat (mean ± SD)

0.18

±

0.23

0.99

±

0.80

0.0037 ^M

**

Years from Tx (mean ± SD)

5.25

±

2.053

6.679

±

2.803

0.1789 ^M

ns